Sign in

CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company

DBV Technologies S.A.

Sign in to watch
Ticker
DBVTF
Exchange
Nasdaq, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
France
Entity type
operating
Phone
330155427878
Business address
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France

Securities

  • DBVT American Depositary Shares Nasdaq
  • DBVTF Common stock OTC
  1. 8-K Event Executive or director change
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. 8-K Event Results of operations
  6. 10-Q Report Quarterly Report
  7. 10-K/A Report 10-K/A
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Results of operations
  10. 10-K Report Annual Report
  11. 8-K Event Other events
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 4 Open-market sale Chief Medical Officer sold 534 shares at $4.86 ($2,595)
  19. 8-K Event Other events
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 2 of 29 · 577 filings